UNSPSC 51283403: Apalcillin

This classification denotes a penicillin antibiotic with the molecular formula C25H23N5O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3373RT9U7A, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((((4-hydroxy-1,5-naphthyridin-3-yl)carbonyl)amino)phenylacetyl)amino)-3,3-dimethyl-7-oxo-, (2s-(2-alpha,5-alpha,6-beta(s*)))- but generally known as apalcillin, which bears US NIH Compound Identifier 107947. Apalcillin most often comes in base and sodium forms.

UNSPSC 51283403 Apalcillin is a Commodity code that captures pharmaceutical products acquired by state and local health agencies through piggyback contracts and direct procurement vehicles. Recent state and local opportunities under this code reflect purchases of specific pharmaceutical products—including antibiotics, opioid antagonists, and related medical supplies—rather than apalcillin exclusively. State and local buyers using this code include state departments of public health, county health departments, and community health authorities. Procurement typically flows through cooperative purchasing consortia such as MMCAP Infuse, which allow smaller jurisdictions to leverage established master agreements and negotiate volume pricing on essential pharmaceuticals and medical supplies.

Illinois Department of Public Health and Seminole County, Florida represent recent activity. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026, totaling $2,999,999.11 over 12 months plus two renewal options, supplying Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets through an Invitation for Bid process. Seminole County, Florida released an IFB on June 30, 2026, for annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries to the Seminole County Community Health Building, with a response deadline of July 26, 2023. Recent activity concentrates in Florida and Illinois; the source does not support characterization of broader geographic spread.